Navigation Links
Neurochem announces departure of two members of management team
Date:2/21/2008

LAVAL, QC, Feb. 21 /PRNewswire-FirstCall/ - In light of Neurochem Inc.'s (NASDAQ: NRMX; TSX: NRM) new strategic direction, the Company announces the departure, effective February 21, 2008, of two members of its senior management team, Dr. Andreas Orfanos, MBB. Ch, MBA, Executive Vice President, Strategic Planning and Scientific Affairs, and Ms. Christine Lennon, MBA, Vice President, Business Development. The possibility of their acting as consultants in respect of specific projects is being explored.

"On behalf of the Board of Directors and my colleagues, I want to express our gratitude to Dr. Orfanos and Ms. Lennon for their dedication and valuable contribution to Neurochem. We wish them every success in the future," said Dr. Francesco Bellini, Neurochem's Chairman, President and CEO.

About Neurochem

Neurochem Inc. is a global health company focused on the research, development and commercialization of products to provide innovative health solutions to address critical unmet medical needs.

To Contact Neurochem

For additional information on Neurochem and its drug development programs, please call the North American toll-free number 1-877-680-4500 or visit our Web Site at http://www.neurochem.com.

Certain statements contained in this news release, other than statements of fact that are independently verifiable at the date hereof, may constitute forward-looking statements. Such statements, based as they are on the current expectations of management, inherently involve numerous risks and uncertainties, known and unknown, many of which are beyond Neurochem Inc.'s control. Such risks include but are not limited to: the impact of general economic cond
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
2. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
3. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
4. Neurochem to present at JPMorgan Healthcare Conference
5. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
6. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
7. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
8. Neurochem reports results for third quarter of fiscal 2007
9. Emergency Dentist 24/7(TM) Announces Worldwide Licensing Program
10. LCA-Vision Announces Quarterly Dividend Payment
11. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...s to bring unprecedented medical, economic burdens...althDay News) -- The number of people with diabete...the next 25 years, a new study predicts. , That...on people with the disease, up from 23.7 million t... people with diabetes will triple, the study also ...
(Date:11/27/2009)... Voyant Health™ announced today... licensed its TraumaCad Enterprise orthopedic temp...solution. , (PRWEB) Novem...ay that Spectrum Health (Grand Rapids, Michigan) h...mplating solution and its TraumaCad Extend workflo...
(Date:11/27/2009)... Specialist manufacturers who use med... saving millions of dollars by bringing in technol...ncreasing numbers of pro-active medical manufactur...e concept stage of their projects, ensuring that p... processes or potentially outdated technology. , ...
(Date:11/26/2009)...ORK,Nov.27/PRNewswire/--Withcoldandfluseasonuponus...ontrolthespreadofinfectionsandavoidillness. ,, ...buttoavoidtransmittingillnessifwe,resick,"saidEile...nursingdirectorforinfectioncontrolandoccupationalh...,, HospitalforSpecialSurgeryhasoneofthelowestin...
(Date:11/26/2009)...t 25 years, the number of Americans living with di...llion in 2009 to 44.1 million in 2034. Over the sa..., rising from $113 billion to $336 billion, even w...archers based at the University of Chicago report ...number of those with diabetes covered by Medicare ...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
...Weiss, breast oncologist and BREASTCANCER.ORG foun...t Cancer Patient Protection ACT, ...atory drive-through,mastectomies is an unconsciona...r and President of Breastcancer.org, in,an open le...
...to ,bad, cholesterol determined chances of trouble...THURSDAY, May 22 (HealthDay News) -- Standard chol...re at risk for heart problems while taking hormon...taking hormone therapy, while women with high leve...
...octor Diabetic Supply, Inc., one of the,nation,s l...announced today,that it has been selected by The C...rovide mail-order diabetic testing supplies to ben... medical,equipment, prosthetics, orthotics, and su...
... Strengthens Publicis Groupe Digital Activities Wi...se Internet Users, PARIS, May 22 Publicis Groupe...-based full-service digital marketing,agency, Empo...ng alongside Arc under the Leo Burnett China umbre...
..., among the most economically costly sports injuri...lated surgeries according to a study conducted at ...f the Research Institute at Nationwide Childrens H...e injury surveillance system which collects injury...
...ay 21 From June 9-11 in New York City,Direct Resp...agement Boot,Camp" tailor-made for nutraceutical a...nts and skin care products can do very well in an,...unique legal and regulatory issues that effect the...
Other Medicine News:Health News:Drive-Through Mastectomies Threaten Patients' Lives 2Health News:Cholesterol Test Spots When HRT Raises Heart Risks 2Health News:Cholesterol Test Spots When HRT Raises Heart Risks 3Health News:Doctor Diabetic Supply Awarded by Medicare to Provide Mail-Order Diabetic Testing Supplies in 10 Metropolitan Areas 2Health News:Publicis Groupe Acquires EmporioAsia, Leading Digital Agency in China 2Health News:Publicis Groupe Acquires EmporioAsia, Leading Digital Agency in China 3Health News:First of its kind study compares high school knee injuries by sport and gender 2Health News:Direct Response TV Course on Nutraceutical/Cosmeceutical Products to Premiere in New York City 2
(Date:11/25/2009)..., LOVELAND,Colo.,Nov.25/PRNewswire-FirstCall/--...f advanceddiagnosticandspecialtyproductstothevete...agnosticsCorporationforthesupplyofbloodgasproducts..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...passionforinnovatinginthefieldofadvancedpoint-of-c...
(Date:11/25/2009)..., PRINCETON,N.J.,Nov.25/PRNewswire-FirstCall/--...aceuticalcompanycommittedtodiscovering,developinga...reportedfinancialresultsforthefiscalyearendedSepte...illionincash,cashequivalentsandshortterminvestment...RG7128 ,, Phase2bTrial ,, InlateNovembe...
(Date:11/25/2009)..., CHICAGOandSTAFA,Switzerland,Nov.25/PRNewswire...rofinnovativehearingsolutions,presentedtheseconded...nthespecialneedsoftheolderpopulation.Theconference...omaroundtheworldandmorethan250clinicianswhoworkeve...ytoshareexperiencesanddiscussthelatestresearchandt...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3FDA Acts to Protect Public Health from Electronic Cigarettes 52470 1FDA Acts to Protect Public Health from Electronic Cigarettes 52470 2FDA Acts to Protect Public Health from Electronic Cigarettes 52470 3Medifast Independent Director Lt Gen Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs 52466 1Medifast Independent Director Lt Gen Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs 52466 2Medifast Independent Director Lt Gen Dennis McCarthy Confirmed as Assistant Secretary of Defense for Reserve Affairs 52466 3Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 1Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 2Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 3Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 4Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 5Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 6Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 7Endologix Reports 42 25 Second Quarter 2009 Revenue Growth 52461 8
...rship Strengthened with Clinical Trials S...PANY, N.J. and ATLANTA, Sept. 6 Image Solutions,I...quire Zurich,Biostatistics, Inc. (ZBI). With the L...gulatory submissions, the acquisition further stre...Consortium (CDISC) capabilities,the FDA-supported ...
...tor to Enter Registration Trials, HAYWARD, Calif.... KOSN ) today announced that it has successfully,... Drug Administration,(FDA) on the design of its TI...s Hsp90 inhibitor tanespimycin as a treatment for ...Special Protocol Assessment (SPA),process, Kosan a...
Other Medicine Technology:Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 2Image Solutions, Inc. Acquires Zurich Biostatistics, Inc. 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 2Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 3Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 4Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 5Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 6Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma 7
...chairs with concave seats and large backrests with...backrests, armrests, and casters and glides. &bull...riety of environments including: industry, educati... care and office. • With reinforced nylon bas...
BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q72-CAB-ERB
BEN/1Q-CAB-ERB - Reinforced Nylon Base - Model 1Q70-CAB-ERB
...chairs with concave seats and large backrests with...backrests, armrests, and casters and glides. &bull...riety of environments including: industry, educati... care and office. • With cast aluminum base &...
Medicine Products: